US Patent Issued to Cellenkos on July 28 for "Populations of enriched regulatory T cells and methods for producing same" (Texas Inventor)

ALEXANDRIA, Va., July 28 -- United States Patent no. 12,692,478, issued on July 28, was assigned to Cellenkos Inc. (Houston).

"Populations of enriched regulatory T cells and methods for producing same" was invented by Simrit Parmar (Houston).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided herein are populations of enriched ex vivo expanded umbilical cord blood-derived regulatory T cells. Also provided are methods of making and using the same."

The patent was filed on March 25, 2022, under Application No. 17/704,623.

*For further information, including images, charts and tables, please visit: http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&...